Navigation Links
Vanda Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
Date:5/8/2008

Presentation Will be Webcast Live and Archived on Company's Website

ROCKVILLE, Md., May 8 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA), a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders, today announced that the company will deliver a corporate presentation on Tuesday, May 13, 2008, at 5:20 p.m. Pacific Time.

The presentation will take place as part of the 2008 Bank of America Healthcare Conference at the Four Seasons, Las Vegas, Nevada. The presentation will be available live on the Vanda Website, where it also will be archived for 30 days.

To access the presentation, log on to http://www.vandapharma.com and click on the Presentations option in the Investor Relations section. Please connect to the website several minutes prior to the start of the live presentation

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) is a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders. The company has three product candidates. Vanda's lead product candidate, Fanapta(TM) (iloperidone), for which Vanda has recently submitted an NDA to the FDA, is a compound for the treatment of schizophrenia. Vanda's second product candidate, tasimelteon (VEC-162), is a compound for the treatment of sleep and mood disorde
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
2. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
3. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
6. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
7. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
8. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
9. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
10. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
11. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... , Aug. 26, 2014   Lycera Corp ... breakthrough oral medicines to treat autoimmune disease and ... today announced the appointment of Harinder Singh ... advisory board.  Dr. Singh will lead the board,s ... Lycera,s multiple ongoing research programs and pipeline of ...
(Date:8/26/2014)... 2014 Trovagene, Inc. (NASDAQ:  TROV) presented ... Moving Assays to the Clinic with an ... Cell Free Tumor DNA in Urine." In this ... Precision Cancer Monitoring (PCM) platform and results from ... detection of tumor DNA mutations from urine samples ...
(Date:8/26/2014)... InstantGMP, Inc., the only cloud-based manufacturing ... pricing structure with increased user accounts to help current ... CFR Part 11 requirements. , “We want to help ... can” said Rick Soltero, President of InstantGMP. “We ... customers to have separate accounts for multiple quality managers ...
(Date:8/26/2014)... Spartan Bioscience today announced the ... Business Development. Mr. Shah is responsible for expanding ... in the United States and international markets. ... and strategic initiatives for the company’s rapid sample-to-result ... Shah was the Global Marketing Product Manager for ...
Breaking Biology Technology:Lycera Appoints Harinder Singh, Ph.D., as Chair of Scientific Advisory Board 2Lycera Appoints Harinder Singh, Ph.D., as Chair of Scientific Advisory Board 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 4Spartan Bioscience Names Charudutt Shah as Director of Business Development 2
... April 4, 2008 Scientists in fields,as diverse ... from the Olympus FluoroPoint(TM) single molecule fluorescence,detection system ... of laboratories around the world, the system, with ... of use, is now,available for the first time ...
... April 4, 2008 Pharmasset,Inc. (Nasdaq: VRUS ) ... held on April 9, 2008 at the St. Regis ... Officer, will,provide an overview of the company,s clinical and ... To access a simultaneous webcast of Mr. Price,s ...
... MISSISSAUGA, ON, April 3 /PRNewswire-FirstCall/ - Vasogen Inc.,(NASDAQ: VSGN ... the,three months ended February 29, 2008. All dollar amounts ... At February 29, 2008, our cash and cash equivalents ... 2007., We incurred a net loss for the ...
Cached Biology Technology:Olympus FluoroPoint(TM) System Provides High-Sensitivity Single Molecule and Protein Interaction Analysis for Screening and Research 2Olympus FluoroPoint(TM) System Provides High-Sensitivity Single Molecule and Protein Interaction Analysis for Screening and Research 3Pharmasset to Present at the Canaccord Adams Hepatitis C Conference on Wednesday, April 9th 2Vasogen Announces First Quarter 2008 Results 2Vasogen Announces First Quarter 2008 Results 3Vasogen Announces First Quarter 2008 Results 4Vasogen Announces First Quarter 2008 Results 5Vasogen Announces First Quarter 2008 Results 6Vasogen Announces First Quarter 2008 Results 7Vasogen Announces First Quarter 2008 Results 8Vasogen Announces First Quarter 2008 Results 9Vasogen Announces First Quarter 2008 Results 10Vasogen Announces First Quarter 2008 Results 11
(Date:8/25/2014)... Ill. Aug. 25, 2014 Riddell, the ... the Translational Genomics Research Institute (TGen), a leader ... Pac-12,s Arizona State University and its Sun Devil ... research study designed to advance athlete concussion detection ... the joint research project will combine molecular information ...
(Date:8/25/2014)... 2014  Scribe Labs unveiled its first product, ... saw its campaign surpass the $50,000 funding goal ... metrics that help an athlete understand how factors ... running mechanics. Built with an advanced 9-axis integrated ... advanced set of running metrics available outside of ...
(Date:8/25/2014)... Baltimore is one of the oldest cities in ... well. With these older buildings often comes a whole host of ... to be mold. Mold is often found in the rafters of ... in the walls often times due to older plumbing that has ... look for mold in regards to the area? Also, what can ...
Breaking Biology News(10 mins):Riddell, TGen team with ASU football to further genetic research into concussion detection 2Riddell, TGen team with ASU football to further genetic research into concussion detection 3runScribe Fitness Wearable Exceeds 200% of Kickstarter Goal in First Week 2Mold Concerns in Baltimore 2
... -- Sunshine Menezes, executive director of the Metcalf Institute for ... Mitchell announced the 2011 winner of The Grantham Prize for ... Economist will receive US$75,000 for "The World,s Lungs: Forests, and ... the state of global forests and the rising threats they ...
... In work published in the June 2011 issue ... and their co-investigators - a multidisciplinary team within the ... - have transferred the concept of redox-sensitive Green Fluorescent ... (FRET) imaging platform. For the FRET-based sensors, a change ...
... world or at least the nice temperate parts. They,ve ... sugar shipments from Argentina, and no native ant species has ... group of Stanford University undergraduate students working on a class ... ant, has been using chemical warfare to combat the Argentine ...
Cached Biology News:$75,000 Grantham Prize winner announced 2$75,000 Grantham Prize winner announced 3Development of a FRET sensor for real-time imaging of intracellular redox dynamics 2Development of a FRET sensor for real-time imaging of intracellular redox dynamics 3Native ants use chemical weapons to turn back invading Argentine ants 2Native ants use chemical weapons to turn back invading Argentine ants 3Native ants use chemical weapons to turn back invading Argentine ants 4
... yeast/leuconostoc overproducer ATP: D-hexose 6- ... One unit of HK will ... in 1 min at 25C ... of G6P-DH will oxidize 1 ...
... RNase H degrades, as an ... DNA hybrids of natural origin, ... of synthetic complexes, e.g. poly(A) x ... 5-phosphate and 3-OH termini. Nearly no ...
Request Info...
SHEEP ANTI BOVINE BETA-LACTOGLOBULIN A...
Biology Products: